{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:52:20Z","timestamp":1791478340411,"version":"4.3.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K16061"],"award-info":[{"award-number":["20K16061"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.clnesp.2026.105126","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T06:29:36Z","timestamp":1789972176000},"page":"105126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Liquid and semisolid enteral nutrition formulations alter the pharmacokinetics of orally administered valproate in rats"],"prefix":"10.1016","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8935-6078","authenticated-orcid":false,"given":"Yoko","family":"Urashima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7576-7287","authenticated-orcid":false,"given":"Michiaki","family":"Myotoku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Airi","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9269-144X","authenticated-orcid":false,"given":"Kazuya","family":"Urashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8993-4333","authenticated-orcid":false,"given":"Tomoyuki","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumi","family":"Kurachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7976-2750","authenticated-orcid":false,"given":"Masami","family":"Nishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5972-946X","authenticated-orcid":false,"given":"Akira","family":"Ashida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9489-5826","authenticated-orcid":false,"given":"Takuro","family":"Kobori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yui","family":"Katsuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0878-5493","authenticated-orcid":false,"given":"Tokio","family":"Obata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnesp.2026.105126_bib1","first-page":"496","article-title":"Intestine, immunity, and parenteral nutrition in an era of preferred enteral feeding","volume":"18","author":"Barrett","year":"2015","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.clnesp.2026.105126_bib2","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.3390\/nu14112180","article-title":"Enteral nutrition overview","volume":"14","author":"Doley","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.clnesp.2026.105126_bib3","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.2146\/ajhp080632","article-title":"Recommendations for the use of medications with continuous enteral nutrition","volume":"66","author":"Wohlt","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.clnesp.2026.105126_bib4","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1017\/S0029665110001576","article-title":"Important drug-nutrient interactions","volume":"69","author":"Mason","year":"2010","journal-title":"Proc Nutr Soc"},{"key":"10.1016\/j.clnesp.2026.105126_bib5","first-page":"514","article-title":"Interactions between drugs and drug-nutrient in enteral nutrition: a review based on evidences","volume":"30","author":"Ferreira","year":"2014","journal-title":"Nutr Hosp"},{"key":"10.1016\/j.clnesp.2026.105126_bib6","first-page":"450","volume":"vol. 37","author":"Chan","year":"2013"},{"key":"10.1016\/j.clnesp.2026.105126_bib7","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jada.2011.09.002","article-title":"Drug-nutrient interactions: a broad view with implications for practice","volume":"112","author":"Boullata","year":"2012","journal-title":"J Acad Nutr Diet"},{"key":"10.1016\/j.clnesp.2026.105126_bib8","doi-asserted-by":"crossref","first-page":"559","DOI":"10.31083\/ph.2019.9532","article-title":"Interaction between phenytoin and enteral nutrients and its influence on gastrointestinal absorption","volume":"74","author":"Urashima","year":"2019","journal-title":"Pharmazie"},{"key":"10.1016\/j.clnesp.2026.105126_bib9","doi-asserted-by":"crossref","first-page":"789","DOI":"10.7150\/ijms.71770","article-title":"Liquid enteral nutrients alter the pharmacokinetics of orally administered carbamazepine in rats","volume":"19","author":"Urashima","year":"2022","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.clnesp.2026.105126_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu12061687","article-title":"Semi-solid nutrients for prevention of enteral tube feeding-related complications in Japanese population: a systematic review and meta-analysis","volume":"12","author":"Kokura","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.clnesp.2026.105126_bib11","doi-asserted-by":"crossref","first-page":"E1247","DOI":"10.1055\/s-0042-117218","article-title":"Semi-solid feeds may reduce the risk of aspiration pneumonia and shorten postoperative length of stay after percutaneous endoscopic gastrostomy (PEG)","volume":"4","author":"Toh","year":"2016","journal-title":"Endosc Int Open"},{"key":"10.1016\/j.clnesp.2026.105126_bib12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000492674","article-title":"Feasibility of international proposed standardized enteral connector for semi-solid formula feeding","volume":"73","author":"Maruyama","year":"2018","journal-title":"Ann Nutr Metab"},{"key":"10.1016\/j.clnesp.2026.105126_bib13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.31083\/ph.2023.3575","article-title":"Semisolid enteral nutrients alter the pharmacokinetics of orally administered levetiracetam in rats","volume":"78","author":"Amadutsumi","year":"2023","journal-title":"Pharmazie"},{"key":"10.1016\/j.clnesp.2026.105126_bib14","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S1474-4422(15)00314-2","article-title":"Valproic acid after five decades of use in epilepsy: time to reconsider the indications of a time-honoured drug","volume":"15","author":"Tomson","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.clnesp.2026.105126_bib15","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00023210-200216100-00003","article-title":"Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy","volume":"16","author":"L\u00f6scher","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.clnesp.2026.105126_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14040811","article-title":"Population pharmacokinetics of valproic acid in pediatric and adult caucasian patients","volume":"14","author":"Teixeira-da-Silva","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.clnesp.2026.105126_bib17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.9740\/mhc.2017.01.010","article-title":"Enteral administration of protein supplement and valproate: a potential pharmacokinetic interaction","volume":"7","author":"VandenBerg","year":"2017","journal-title":"Ment Health Clin"},{"key":"10.1016\/j.clnesp.2026.105126_bib18","series-title":"Racol NF liquid for enteral use product information","year":"2023"},{"key":"10.1016\/j.clnesp.2026.105126_bib19","series-title":"Racol NF SemiSolid for Enteral Use product information","year":"2022"},{"key":"10.1016\/j.clnesp.2026.105126_bib20","series-title":"Terumeal soft series product information","year":"2026"},{"key":"10.1016\/j.clnesp.2026.105126_bib21","series-title":"Mermed one product information","year":"2022"},{"key":"10.1016\/j.clnesp.2026.105126_bib22","series-title":"Ltd. F2\u03b1 product information","year":"2022"},{"key":"10.1016\/j.clnesp.2026.105126_bib23","series-title":"Renalen LP product information","year":"2025"},{"key":"10.1016\/j.clnesp.2026.105126_bib24","series-title":"Ensure liquid product information","year":"2019"},{"key":"10.1016\/j.clnesp.2026.105126_bib25","series-title":"Medif pushcare 2.5 product information","year":"2023"},{"key":"10.1016\/j.clnesp.2026.105126_bib26","first-page":"378","article-title":"HPLC determination of valproic acid in human serum","volume":"58","author":"Kishore","year":"2003","journal-title":"Pharmazie"},{"key":"10.1016\/j.clnesp.2026.105126_bib27","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/jpen.2542","article-title":"Study on enteral nutrient components causing decreased gastric phenytoin absorption","volume":"47","author":"Urashima","year":"2023","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.clnesp.2026.105126_bib28","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/00004714-199212000-00010","article-title":"High-fiber diet and serum tricyclic antidepressant level","volume":"12","author":"Stewart","year":"1992","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.clnesp.2026.105126_bib29","first-page":"221","article-title":"Interaction of drugs with dietary fiber -Absorption of drugs onto dietary fiber in in vitro study-","volume":"32","author":"Watanabe","year":"2006","journal-title":"Jpn J Phrm Health Care Sci"},{"key":"10.1016\/j.clnesp.2026.105126_bib30","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00007691-197901000-00011","article-title":"Valproic acid: in vitro plasma protein binding and interaction with phenytoin","volume":"1","author":"Cramer","year":"1979","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.clnesp.2026.105126_bib31","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.foodchem.2017.07.066","article-title":"Characterization and effects of binding of food-derived bioactive compounds to food proteins","volume":"239","author":"Minic","year":"2017","journal-title":"Food Chem"},{"key":"10.1016\/j.clnesp.2026.105126_bib32","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1016\/j.xphs.2024.07.016","article-title":"Characterization of oral drug absorption from jelly formulations: effects of membrane permeability and intestinal fluid volume","volume":"113","author":"Nakamura","year":"2024","journal-title":"J Pharm Sci"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457726022230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457726022230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:02:38Z","timestamp":1791475358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457726022230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":32,"alternative-id":["S2405457726022230"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2026.105126","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liquid and semisolid enteral nutrition formulations alter the pharmacokinetics of orally administered valproate in rats","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2026.105126","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105126"}}